Worst performer was BLU:Blue Star Capital which lost half of last week's
inexplicable gains and dropped 18%.
SBTX:SkinBioTherapeutics fell another 13% as my recent investment is
decimated.
KIBO:Kibo Energy dropped 10% and I'm sure will never recover from the current
100% loss.
On the brighter side, ASHM:Ashmore Group recovered from an utterly miserable
few months by rising 6%, but is still 40% down.
BARC:Barclays also rose 6% but is still 14% down in my trading account.
CEY:Centamin responded to the increase in gold price better than EDV:Endeavour
Mining and climbed 6% to go 24% down.
PAGE:Page Group keep flirting with going into profit, and climbed 6% to go
only 5% down. Will I be able to bed them into my ISA soon without having to
record a paper loss?
ANTO:Antofagasta went up 7% and are now only 9% down so also getting towards profitability.
CAML:Cental Asia Metals are now one of my larger holdings and climbed 7% so my
most recent purchase is only 1% down.
CWR:Ceres Power are so volatile, but this week in the right direction as they
increased 7%.
III:3i Group have been a rare example of a successful magic formula share, and
rose 7% to go 33% up.
Share of the Week is PSN:Persimmon which climbed 8% for no reason I could
detect, and are now only 15% down.
Here's the ISA and shares portfolio after week 16 of year 9.
Weekly Change | |||
Cash | £165.60 | -£3.80 | |
Portfolio cost | £99,082.34 | +£0 | |
Portfolio sell value (bid price-commission) |
£52,593.69 | (-46.9%) | -£1,152.08 |
Potential profits | £2,530.20 | -£256.14 | |
Yr 9 Dividends | £147.01 | +£0.11 | |
Yr 9 Interest | £2.46 | +£0 | |
Yr 9 Profit from sales | £0 | +£0 | |
Yr 9 proj avg monthly profit | £33.10 | (0.6%) | -£8.91 |
Total Dividends | £12,058.44 | +£0.11 | |
Total Interest | £4.39 | +£0 | |
Total Profit from sales | £17,298.53 | +£0 | |
Average monthly cash profit | £290.45 | (4.9%) | -£2.07 |
(Sold stocks profit + Dividends - Fees / Months) |
|||
Compound performance | 41% | +0% |
Not much going on. The 11p dividend was a fractional sum following the share consolidation at RDT:Rosslyn Data and is probably the only return I will ever get from that investment.
The decline continues
Touching the trend line but not below it
The SIPP looks like this after week 416 overall and week 52 of year 8.
Weekly Change | ||||
Cash | £351.82 | -£1.44 | ||
Portfolio cost | £99,680.94 | +£0 | ||
Portfolio sell value (bid price - commission) |
£57,126.53 | (-42.7%) | -£281.81 | |
Potential profits | £4,075.35 | +£4.32 | ||
Yr 8 Dividends | £492.10 | +£0 | ||
Yr 8 Interest | £5.68 | +£0 | ||
Yr 8 Profit from sales | -£9,597.85 | +£0 | ||
Yr 8 proj avg monthly profit | -£771.75 | (-13.6%) | +£15.01 | |
Total Dividends | £14,634.88 | +£0 | ||
Total Interest | £5.93 | +£0 | ||
Total Profit from sales | £10,835.90 | +£0 | ||
Average monthly cash profit | £253.55 | (4.5%) | -£0.62 | |
(Sold stocks profit + Dividends - Fees / Months) |
||||
Compound performance | 36% | +0% |
Much smaller losses in this account thanks to the gains in other stocks.
Looks nice and flat. Still encouragingly close to the injection line.
The trading account looks like this after week 382 overall and week 18 of year 8.
Weekly Change | |||
Cash | £281.80 | +£0 | |
Portfolio cost | £1,794.51 | +£0 |
|
Portfolio sell value (bid price - commission) |
£953.67 | (-46.9%) | +£12.65 |
Potential profits | £0 | +£0 | |
Year 8 Dividends | £8.56 | +£0 | |
Year 8 Interest | £0 | +£0 | |
Year 8 Profit | £283.99 | +£0 | |
Yr 8 proj avg monthly profit | £70.43 | (+47.1%) | -£4.14 |
Dividends | £68.66 | +£0 | |
Interest | £0.03 | +£0 | |
Profit from sales | -£646.70 | +£0 | |
Average monthly cash profit | -£6.56 | (-4.4%) | +£0.01 |
(Sold stocks profit + Dividends - Fees / Months) |
A rare increase in value!
Have we bottomed out?
Still a long way to go to recover.
That's 2 out of 3 weeks caught up. One more to go...
No comments:
Post a Comment